We first analyzed the data from individuals with Sotos syndrome, a congenital overgrowth syndrome that results from mutation of the epigenetic modifier NSD1 (Supplemental Table S5), a lysine histone methyltransferase (Kurotaki et al. 2002; Qiao et al. 2011). Here, NSD1 is linked to Sotos syndrome.